COVID Shots Associated With Increased Risk of Blindness (mercola.com)
While U.S. health agencies have admitted that myocarditis (heart inflammation), and a related condition called pericarditis (inflammation of the heart sack), are potential side effects of the COVID jab,1 the U.S. Centers for Disease Control and Prevention has ignored hundreds of other safety signals that have shown up during their Proportional Reporting Ratio (PRR) data mining of the Vaccine Adverse Event Reporting System (VAERS). For example, in individuals aged 18 and older, there are 770 safety signals for different adverse events, and more than 500 of them have a stronger safety signal than myocarditis and pericarditis.2
Two recent papers specifically highlight the risk of ophthalmic vascular events, which can lead to blindness, following the COVID jab. Across age groups, the risk more than doubled in the two years following the shot. According to Retsef Levi, that amounts to one additional case for every 300 seniors jabbed (age 64 and older), and one additional case for every 1,000 people jabbed between the ages of 18 and 64. Basically, what we’re talking about are acute ischemic strokes that affect the eyes and can cause permanent loss of vision. It’s important to realize that the primary symptom of retinal vascular occlusion is a sudden change in vision — be it blurry vision, or a partial or complete loss of vision — typically only in one eye. Rarely ever is there pain. Should this happen, seek evaluation immediately. A systematic review of 49 studies published in the journal Vaccines in December 2022, found that most vascular events involving the eyes (46.2%) occurred after the first dose, and were more common after the Pfizer and AstraZeneca shots.
Treatment modalities, including medical therapies, laser photocoagulation, and other surgical therapies Retinal vein occlusion: Treatment – UpToDate
Anti-Aging Lady 